www.hivandhepatitis.com

Coverage of the 2017 IAS Conference on HIV Science

HIVandHepatitis.com coverage of the 9th International AIDS Society Conference on HIV Science, July 23-26, 2017, in Paris.

Antiretroviral Therapy

• Doravirine Combo Pill Looks Good for Initial HIV Treatment
• Boosted Darunavir Plus Lamivudine Matches 3-Drug Regimen
• Trans Women Wary of Antiretroviral Drug and Hormone Interactions
• Novel Long-Acting Drug Shows Promise for HIV Treatment and PrEP
• First Protease Inhibitor Combo Pill Maintains Viral Suppression
• Long-Acting Cabotegravir + Rilpivirine Looks Good for HIV ART
• New HIV Integrase Inhibitor Bictegravir Works Well for First-Line Treatment IAS

HIV Cure Research

• Cancer Research May Offer Clues for HIV Cure Research -- and Vice Versa
• Why Curing Cancer May Be Like Curing HIV -- and May Be As Difficult
• VRC01 Antibody Can Delay But Not Prevent HIV Rebound
• South African Child Has Controlled HIV Off Treatment for 8.5 Years

HIV Prevention

• Experts Agree that Intermittent Oral PrEP Probably Won't Work for Women
• Who Are Trans Women Acquiring HIV From?
• PrEP Use in U.S. Exceeds 100,000 in Gilead Pharmacy Survey
• Medical Male Circumcision for HIV Prevention Has Benefits for Women Too
• Another HIV Vaccine Efficacy Trial Will Start This Year
• Demonstration Projects Explore Feasibility of PrEP for Adolescents in South Africa
• Study of Gay Couples Shows No Transmissions from Undetectable HIV+ Partners
• Long-Acting Cabotegravir Shows Promise For HIV Prevention
• PrEP Still Protected People Who Had Less Sex in Ipergay Study

HIV-Related Conditions and Comorbidities

• Switch from Boosted Protease Inhibitor to Dolutegravir Reduces Lipids in People with HIV
• Acute Kidney Injury Uncommon on Tenofovir, No Link Seen to Bone Breaks
• People with HIV Are at Risk for Liver Fibrosis and Steatosis

HIV Epidemiology and Access to Care

• Aim for $90-$90-$90 Target on HIV, Hepatitis, and TB Drug Prices, Study Says
• Improved Cryptococcal Meningitis Treatment Could Save Thousands of Lives
• WHO Recommends Urgent Care Package for People with Advanced HIV Disease
• World On Track To Reach 90-90-90 Targets for HIV Treatment by 2020
• New HIV Infections Halved as Treatment Scales Up in Swaziland

Hepatitis C and HIV/HCV Coinfection

• Glecaprevir/Pibrentasvir Effective for People with HIV/HCV Coinfection
• Hepatitis C Treatment is Effective and Feasible in Africa